Hepatitis C virus vaccine design: focus on the humoral immune response-Reference-Cited by-同舟云学术

Hepatitis C virus vaccine design: focus on the humoral immune response

Published:2020-07-06 Issue:1 Volume:27 Page:
ISSN:1423-0127
Container-title:Journal of Biomedical Science
language:en
Short-container-title:J Biomed Sci

Author:

Sepulveda-Crespo Daniel,Resino Salvador,Martinez Isidoro

Funder

Instituto de Salud Carlos III

Ministerio de Ciencia, Innovación y Universidades

Fundación ONCE

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biochemistry (medical),Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12929-020-00669-4.pdf

Reference163 articles.

1. Adams RL, Pirakitikulr N, Pyle AM. Functional RNA structures throughout the hepatitis C virus genome. Curr Opin Virol. 2017;24:79–86.

2. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318–27.

3. Forns X, Purcell RH, Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol. 1999;7(10):402–10.

4. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288(5464):339–44.

5. Polaris Observatory HCVC. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161–76.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept;Vaccine;2024-10

2. Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study;Pharmaceuticals;2024-08-30

3. Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study;Journal of Education and Health Promotion;2024-06

4. Immune Responses to Anti-Hepatitis C Virus Antibodies during Pre-Liver Transplantation Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Recipients Associated with Post-Liver Transplantation Allograft Injury;Antibodies;2024-01-16

5. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine;Pathogens;2023-12-31